Determination of lipoic acid in human plasma by HPLC-ECD using liquid-liquid and solid-phase extraction: method development, validation and optimization of experimental parameters
Khan, Abad and Khan, Muhammad I. and Iqbal, Zafar and Ahmad, Lateef and Shah, Yasar and Watson, David G. (2010) Determination of lipoic acid in human plasma by HPLC-ECD using liquid-liquid and solid-phase extraction: method development, validation and optimization of experimental parameters. Journal of Chromatography B, 878 (28). pp. 2782-2788. ISSN 1570-0232 (https://doi.org/10.1016/j.jchromb.2010.08.022)
Full text not available in this repository.Request a copyAbstract
A rapid, inexpensive, sensitive and specific HPLC-ECD method for the determination of lipoic acid in human plasma was developed and validated over the linearity range of 0.001-10 mu g/ml using naproxen sodium as an internal standard (IS). Extraction of lipoic acid and IS from plasma (250 mu l) was carried out with a simple one step liquid-liquid extraction using dichloromethane. Similarly solid-phase extraction was carried out using dichloromethane as extraction solvent. The separated organic layer was dried under the stream of nitrogen at 40 degrees C and the residue was reconstituted with the mobile phase. Complete separation of both lipoic acid and IS at 30 degrees C on Discovery HS C18 RP column (250 mm x 4.6 mm, 5 mu m) was achieved in 6 min using 0.05 M phosphate buffer (pH 2.5 adjusted with phosphoric acid):acetonitrile (50:50, v/v) as a mobile phase pumped at the rate of 1.5 ml/min using electrochemical detector in DC mode at the detector potential of 1.0 V. The limit of detection and limit of quantification of lipoic acid were 200 pg/ml and 1 ng/ml, respectively. While on column limit of detection and limit of quantification of lipoic acid were 10 and 50 pg/ml, respectively. The absolute recoveries of lipoic acid with liquid-liquid and solid-phase extraction were 98.43, 95.65, 101.45, and 97.36, 102.73, 100.17% at 0.5, 1 and 5 mu g/ml levels, respectively. Coefficient of variations for both intra-day and inter-day were between 0.28 and 4.97%. The method is validated and will be quite suitable for the analysis of lipoic acid in the plasma of human volunteers as well as patients with diabetes and cardiovascular diseases. (C) 2010 Elsevier B.V. All rights reserved.
ORCID iDs
Khan, Abad, Khan, Muhammad I., Iqbal, Zafar, Ahmad, Lateef, Shah, Yasar and Watson, David G. ORCID: https://orcid.org/0000-0003-1094-7604;-
-
Item type: Article ID code: 39888 Dates: DateEvent15 October 2010PublishedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Strathclyde Business School > EconomicsDepositing user: Pure Administrator Date deposited: 31 May 2012 11:09 Last modified: 11 Nov 2024 10:08 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/39888